0001708138-20-000108.txt : 20201118 0001708138-20-000108.hdr.sgml : 20201118 20201118160215 ACCESSION NUMBER: 0001708138-20-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201324894 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-16 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2020-11-16 4 M 0 13736 30.63 A 60872 D Common Stock 2020-11-16 4 F 0 7108 561.39 D 53764 D Common Stock 2020-11-17 4 S 0 743 536.68 D 53021 D Common Stock 2020-11-17 4 S 0 229 537.38 D 52792 D Common Stock 2020-11-17 4 S 0 591 538.37 D 52201 D Common Stock 2020-11-17 4 S 0 42 539.87 D 52159 D Common Stock 2020-11-17 4 S 0 1442 540.49 D 50717 D Common Stock 2020-11-17 4 S 0 812 541.42 D 49905 D Common Stock 2020-11-17 4 S 0 294 542.37 D 49611 D Common Stock 2020-11-17 4 S 0 467 543.65 D 49144 D Common Stock 2020-11-17 4 S 0 68 544.01 D 49076 D Common Stock 2020-11-17 4 S 0 171 545.47 D 48905 D Common Stock 2020-11-17 4 S 0 524 546.61 D 48381 D Common Stock 2020-11-17 4 S 0 148 547.12 D 48233 D Common Stock 2020-11-17 4 S 0 216 548.77 D 48017 D Common Stock 2020-11-17 4 S 0 283 549.67 D 47734 D Common Stock 2020-11-17 4 S 0 206 550.71 D 47528 D Common Stock 2020-11-17 4 S 0 141 551.48 D 47387 D Common Stock 2020-11-17 4 S 0 73 552.88 D 47314 D Common Stock 2020-11-17 4 S 0 64 553.21 D 47250 D Common Stock 2020-11-17 4 S 0 114 556.45 D 47136 D Common Stock 4242 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2020-11-16 4 M 0 13736 0.0 D 2020-12-14 Common Stock 13736 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 743 shares of Company stock on November 17, 2020 at prices ranging from $536.41 to $536.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 229 shares of Company stock on November 17, 2020 at prices ranging from $537.15 to $537.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 591 shares of Company stock on November 17, 2020 at prices ranging from $538.03 to $538.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 42 shares of Company stock on November 17, 2020 at prices ranging from $539.50 to $539.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 1,442 shares of Company stock on November 17, 2020 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 812 shares of Company stock on November 17, 2020 at prices ranging from $541.01 to $541.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 294 shares of Company stock on November 17, 2020 at prices ranging from $542.15 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 467 shares of Company stock on November 17, 2020 at prices ranging from $543.07 to $543.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 171 shares of Company stock on November 17, 2020 at prices ranging from $545.37 to $545.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 524 shares of Company stock on November 17, 2020 at prices ranging from $546.08 to $546.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 148 shares of Company stock on November 17, 2020 at prices ranging from $547.12 to $547.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 216 shares of Company stock on November 17, 2020 at prices ranging from $548.47 to $548.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 283 shares of Company stock on November 17, 2020 at prices ranging from $549.03 to $549.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 206 shares of Company stock on November 17, 2020 at prices ranging from $550.52 to $550.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 141 shares of Company stock on November 17, 2020 at prices ranging from $551.31 to $551.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. Represents volume-weighted average price of sales of 114 shares of Company stock on November 17, 2020 at prices ranging from $556.38 to $556.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Andrew Murphy 2020-11-18